Term ends May 31, 2027 · Medium confidence
20-year base term ends May 31, 2027
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 8,980,260), so the cap could be lower.
May 31, 2007
May 31, 2027
Jun 13, 2017
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 31, 2007, when application 11/806,472, the earliest non-provisional in its chain, was filed (this one was filed Jun 18, 2014) | May 31, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,226,943, US 8,425,903, US 8,980,260, US 9,505,832) | resolves to May 31, 2027, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 31, 2027 | Medium confidence |
This family
| US 7,919,092 | In force Feb 2028 | Feb 2028 |
| US 8,206,713 | In force May 2027 | May 2027 |
| US 8,404,237 | In force May 2027 | May 2027 |
| US 8,784,811 | Lapsed on the fee record Jul 2026 | Jul 2026 |
| US 9,676,865 | this patent May 2027 | May 2027 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 1, 2014 Reel 33863, frame 17 | Lewicki, John; Gurney, Austin; Hoey, Timothy; Yen, Wan-ching; Satyal, Sanjeev | Oncomed Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Dec 22, 2014 Reel 34569, frame 636 | Lewicki, John A.; Gurney, Austin L.; Hoey, Timothy C.; Yen, Wan-ching; Satyal, Sanjeev H. | Oncomed Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Oct 23, 2020 Reel 54193, frame 78 | Oncomed Pharmaceuticals, Inc. | Mereo Biopharma 5, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,226,943, US 8,425,903, US 8,980,260, US 9,505,832, ends no earlier than this term, so it caps nothing.